Articles by Gary Walsh, PhD - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Gary Walsh, PhD

Biopharmaceuticals: Approval Trends in 2005

Aug 1, 2006

In 2005, 10 biopharma- ceuticals gained marketing approval in the US or Europe, although only five of them were genuinely new molecular entities.

Biopharmaceuticals: Approvals and Approval Trends in 2004

Twelve biopharmaceuticals gained marketing approval in the US and EU in 2004. Antibody-based products represented the single largest product category.
May 1, 2005

Cancer remains the primary indication (three products), again mirroring recent approval trends.

Modern Antibody-Based Therapeutics

Antibody-mediated therapy is based upon the high binding specificity exhibited by antibodies for the antigen against which they are produced.
Dec 1, 2004

As of late 2004, 26 modern antibody-based therapeutic agents have been approved in the European Union and the US. Some 500 such products are currently in development, ensuring that the number of approved antibody-based products will increase substantially over the coming years.

ADVERTISEMENT

ADVERTISEMENT

Click here